Skip to main content
. Author manuscript; available in PMC: 2015 Jul 16.
Published in final edited form as: Ann Surg Oncol. 2012 Jul 6;19(11):3335–3342. doi: 10.1245/s10434-012-2469-1

Figure 1. Breakdown of patients.

Figure 1

Of the total 284 patients with thin melanomas who were included in the study, 271 patients had a sentinel lymph node biopsy (SLNB) while 13 patients did not have a SLNB at the time of primary excision but subsequently developed a nodal recurrence (NR) as first site of recurrence. All patients with evidence of nodal metastases were combined to form the node-positive group (37 patients) consisting of 22 positive SLNB patients, 13 NR patients and 2 false-negative SLNB patients.